Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.840
+0.140 (8.24%)
At close: Oct 2, 2025, 4:00 PM EDT
1.880
+0.040 (2.17%)
After-hours: Oct 2, 2025, 7:51 PM EDT

Propanc Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
Net Income
-58.92-1.82-2.66-2.66-2.03
Upgrade
Depreciation & Amortization
0.020.020.020.010
Upgrade
Other Amortization
0.30.290.20.050.14
Upgrade
Stock-Based Compensation
55.97-0.140.390.21
Upgrade
Other Operating Activities
1.090.150.720.610.09
Upgrade
Change in Accounts Payable
0.190.240.080.020.18
Upgrade
Change in Other Net Operating Assets
0.950.180.390.150.26
Upgrade
Operating Cash Flow
-0.41-0.94-1.11-1.44-1.15
Upgrade
Short-Term Debt Issued
0.540.840.590.770.33
Upgrade
Long-Term Debt Issued
0.340.22---
Upgrade
Total Debt Issued
0.891.060.590.770.33
Upgrade
Short-Term Debt Repaid
-0.13-0.14---0.04
Upgrade
Total Debt Repaid
-0.13-0.14---0.04
Upgrade
Net Debt Issued (Repaid)
0.760.920.590.770.28
Upgrade
Issuance of Common Stock
-0.020.520.720.78
Upgrade
Other Financing Activities
-0.26----
Upgrade
Financing Cash Flow
0.490.941.111.491.06
Upgrade
Foreign Exchange Rate Adjustments
-0.090-0-0.050.02
Upgrade
Net Cash Flow
-0.010.010.010-0.06
Upgrade
Free Cash Flow
-0.41-0.94-1.11-1.44-1.15
Upgrade
Free Cash Flow Per Share
-0.10----
Upgrade
Cash Interest Paid
0.030.01000.01
Upgrade
Levered Free Cash Flow
12.9-0.78-0.51-1.5-0.77
Upgrade
Unlevered Free Cash Flow
12.95-0.66-0.38-1.19-0.63
Upgrade
Change in Working Capital
1.140.420.470.170.44
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.